Anti-Nucleoprotein of Dobrava Virus (DOBV). IgG fraction monoclonal antibody. Clone 3A1/H9

Anti-Nucleoprotein of Dobrava Virus (DOBV). IgG fraction monoclonal antibody. Clone 3A1/H9

Catalog Number:
A001277615AUS
Mfr. No.:
AUST_HNM-6031BZ1-5
Price:
$878
  • Size:
    100µg
    Quantity:
    Add to Cart:
      • Overview
        • Mouse monoclonal antibody IgG fraction (clone 3A1/H9) obtained by immunizing mice with purified recombinant DOBV Nucleoprotein. The IgG fraction was purified using Protein G-Sepharose.

          Please contact us at for specific academic pricing.

      • Properties
        • Antibody Type
          monoclonal
          Isotype
          IgG1
          Formulation
          Solution at 1.0 mg/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.
          Storage
          Store at -20°C.

          * For research use ONLY in laboratory animals and in vitro testing. NOT for diagnostic or human use.

      • Applications
        • Application Description
          This antibody can be used in ELISA (1:30,000 dilution) and Western blot (1:15,000 dilution) analysis. It recognizes the nucleoprotein of DOBV and it has cross reactivity with nucleoproteins of Seoul Virus (SEOV) and Hantaan Virus (HTNV). Hantaviruses (family Bunyaviridae) are enveloped viruses that contain a tripartite, negative-stranded RNA genome encoding an RNA-dependent RNA polymerase (L), two integral membrane glycoproteins (G1 and G2), and a nucleocapsid (N) protein. The N protein is the most abundant viral component and the major antigen in early serological response in humans and mice. It has essential functions in viral RNA replication, encapsidation, and also in virus assembly. DOBV causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different rodent species, Apodemus flavicollis and Apodemus agrarius.
      • Reference
        • Klempa, B. et al. (2004) J. Clin. Microbiol. 42, 1322-1325.
          Vapalahti, O. et al (2003) Lancet Infect. Dis. 3, 653-661.
          Sibold, C. et al (2001) J. Med. Virol. 63, 158-167.
          Avsic-Zupanc, T. et al. (1995) J. Gen. Virol. 76, 2801-2808.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.